DURATION OF STARTING bDMARDs ARE ALMOST 3 TIMES LONGER IN RA PATIENTS THAN PsA PATIENTS: HUR-BIO REAL LIFE RESULTS

被引：0
|
作者：
Yardimci, G. K. [1 ]
Farisogullari, B. [1 ]
Bolek, E. C. [1 ]
Bilgin, E. [1 ]
Duran, E. [1 ]
Ayan, G. [1 ]
Ozsoy, Z. [1 ]
Uzun, G. Sandal [1 ]
Kilic, L. [1 ]
Akdogan, A. [1 ]
Karadag, O. [1 ]
Bilgen, S. A. [1 ]
Kiraz, S. [1 ]
Ertenli, A. I. [1 ]
Kalyoncu, U. [1 ]
机构：
[1] Hacettepe Univ, Rheumatol, Fac Med, Ankara, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.3283
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0633
引用
收藏
页码：554 / 555
页数：2
相关论文
共 32 条
  • [21] Patients with Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Had Similar TNFi Drug Survival: HUR-BIO Real Life Results
    Kalyoncu, Umut
    Karadag, Omer
    Kilic, Levent
    Bilgen, Sule Apras
    Erden, Abdulsamet
    Akdogan, Ali
    Kiraz, Sedat
    Ertenli, Ihsan
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S66 - S66
  • [22] BIOLOGICAL THERAPY IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS FOLLOWED IN ADULT RHEUMATOLOGY DEPARTMENT: HUR-BIO REAL LIFE RESULTS
    Kilic, L.
    Sari, A.
    Armagan, B.
    Erden, A.
    Karadag, O.
    Akdogan, A.
    Bilgen, S. Apras
    Kiraz, S.
    Ozen, S.
    Kalyoncu, U.
    Ertenli, A. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 402 - 402
  • [23] PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS HAD SIMILAR TNFI DRUG SURVIVAL: HUR-BIO REAL LIFE RESULTS
    Kalyoncu, U.
    Karadag, O.
    Kilic, L.
    Bilgen, S. A.
    Akdogan, A.
    Kiraz, S.
    Ertenli, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 718 - 718
  • [24] EFFICACY, RETENTION RATE AND PREDICTORS OF TOFACITINIB EFFICACY AND RETENTION IN RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL-LIFE EXPERIENCE
    Bilgin, E.
    Ceylan, F.
    Bolek, E. C.
    Duran, E.
    Farisogullari, B.
    Yardimci, G. K.
    Kilic, L.
    Akdogan, A.
    Karadag, O.
    Bilgen, S. A.
    Kiraz, S.
    Ertenli, A. I.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1460 - 1460
  • [25] Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
    Emine Duran
    Zeynep Ozge Ozturk
    Emre Bilgin
    Yahya Büyükaşık
    Omer Dizdar
    Gozde Kubra Yardimci
    Bayram Farisogullari
    Zehra Özsoy
    Gizem Ayan
    Gullu Sandal Uzun
    Mustafa Ekici
    Erdinc Unaldi
    Levent Kilic
    Ali Akdoğan
    Omer Karadag
    Şule Apraş Bilgen
    Sedat Kiraz
    Umut Kalyoncu
    Ali Ihsan Ertenli
    Rheumatology and Therapy, 2023, 10 : 969 - 981
  • [26] Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis; Hur-BIO Real Life Experiences
    Uyaroglu, Oguz Abdullah
    Seyhoglu, Emrah
    Erden, Abdulsamet
    Kilic, Levent
    Armagan, Berkan
    Sari, Alper
    Karadag, Omer
    Akdogan, Ali
    Bilgen, Sule Apras
    Kiraz, Sedat
    Ertenli, Ihsan
    Kalyoncu, Umut
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [27] Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
    Duran, Emine
    Ozturk, Zeynep Ozge
    Bilgin, Emre
    Buyukasik, Yahya
    Dizdar, Omer
    Yardimci, Gozde Kubra
    Farisogullari, Bayram
    Ozsoy, Zehra
    Ayan, Gizem
    Uzun, Gullu Sandal
    Ekici, Mustafa
    Unaldi, Erdinc
    Kilic, Levent
    Akdogan, Ali
    Karadag, Omer
    Bilgen, Sule Apras
    Kiraz, Sedat
    Kalyoncu, Umut
    Ertenli, Ali Ihsan
    RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 969 - 981
  • [28] Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results
    Armagan, Berkan
    Sari, Alper
    Erden, Abdulsamet
    Kilic, Levent
    Erdat, Efe Cem
    Karadag, Omer
    Akdogan, Ali
    Bilgen, Sule Apras
    Ertenli, Ihsan
    Kiraz, Sedat
    Kalyoncu, Umut
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [29] Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results
    Seyhoglu, Emrah
    Uyaroglu, Oguz Abdullah
    Erden, Abdulsamet
    Kilic, Levent
    Armagan, Berkan
    Sari, Alper
    Karadag, Omer
    Bilgen, Sule Apras
    Akdogan, Ali
    Ertenli, Ihsan
    Kalyoncu, Umut
    Kiraz, Sedat
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] CHANGES IN THE PRESCRIPTION PATTERNS OF THE SECOND-LINE BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY
    Kiraz, S.
    Kalyoncu, U.
    Karadag, O.
    Kilic, L.
    Akdogan, A.
    Dogan, I.
    Bilgen, S. A.
    Bilgin, E.
    Bolek, E. C.
    Kicasik, B.
    Maras, Y.
    Erden, A.
    Armagan, B.
    Sari, A.
    Duran, E.
    Farisogullari, B.
    Yardimci, G. K.
    Ozsoy, Z.
    Ayan, G.
    Calguneri, M.
    Ertenli, A. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1124 - 1125
1234